Elevance Health Inc.

NYSE: ANTM · Real-Time Price · USD
482.58
12.71 (2.71%)
At close: Jun 28, 2022, 6:00 AM

Elevance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
38.63B 38.09B 36.58B 35.82B 33.85B 32.38B
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
38.63B 38.09B 36.58B 35.82B 33.85B 32.38B
Operating Income
2.35B 2.54B 1.61B 2.2B 2.55B 2.37B
Interest Income
n/a n/a n/a n/a n/a n/a
Pretax Income
2.14B 2.33B 1.4B 2B 2.35B 2.18B
Net Income
1.65B 1.79B 1.13B 1.51B 1.79B 1.67B
Selling & General & Admin
4.27B 4.34B 4.22B 3.95B 3.82B 3.92B
Research & Development
n/a n/a n/a n/a n/a n/a
Other Expenses
29.15B -39.9B -39.19B -37.56B -35.12B -33.94B
Operating Expenses
33.42B -35.56B -34.97B -33.62B -31.3B -30.02B
Interest Expense
208M 201M 200M 201M 205M 192M
Selling & Marketing Expenses
2.43B n/a n/a n/a n/a n/a
Cost & Expenses
36.49B 35.77B 35.18B 33.83B 31.5B 30.21B
Income Tax Expense
493M 531M 275M 494M 552M 509M
Shares Outstanding (Basic)
240.7M 241.4M 241.77M 243.4M 244.5M 244.94M
Shares Outstanding (Diluted)
243.4M 244.4M 245.5M 246M 247.4M 248.2M
EPS (Basic)
6.86 7.44 4.65 6.20 7.33 6.80
EPS (Diluted)
6.78 7.34 4.58 6.13 7.25 6.71
EBITDA
2.75B 2.9B 1.97B 2.56B 2.86B 2.65B
EBIT
2.35B 2.53B 1.6B 2.34B 3.03B 2.57B
Depreciation & Amortization
393M 358M 360M 351M 309M 282M